Utilized for major depressive disorder to manage mood stability and support emotional well-being.
Mechanism of Action
Citalopram inhibits the presynaptic reuptake of serotonin (5-HT), increasing its availability in the synaptic cleft. It has minimal effect on norepinephrine and dopamine reuptake.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
35 hours (half-life)
Contraindications
Concurrent use of MAO inhibitors, Concurrent use of pimozide, Congenital long QT syndrome
Information related to Citalopram is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
